Added to YB: 2024-09-17
Pitch date: 2024-09-13
COV.V [bullish]
Covalon Technologies Ltd.
-35.92%
current return
Author Info
An Exploration of Microcapland is a full-time microcap investor sharing investment ideas in their newsletter. Sign up for the newsletter.
Company Info
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
Market Cap
CAD 65.8M
Pitch Price
CAD 2.86
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.34
P/E
27.87
EV/Sales
1.48
Sector
Biotechnology
Category
growth
Covalon Technologies Ltd. - $COV.V
COV.V: Med tech co w/ 3 platforms. Q3 net profit C$1.7M, annualized EV/E 11.1x. US product sales 87% of rev, growing 21% QoQ. New CEO from 3M. Strong growth in collagen & antimicrobial products. 60+ new customers in 9 months. Potential for continued growth despite historical volatility.
Read full article (13 min)